Central non-small cell lung cancer
Conditions
Interventions
Case series:Gemcitabine Drug-Eluting Beads Transarterial Chemoembolization by Callispheres Beads
Sponsors
Minimally Invasive Tumor Therapies Center, Beijing Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Aged 18-75 years male and female; 2) Non-small cell lung cancer was diagnosed by histopathology, and central lung cancer was classified by CT and other imaging examination; 3) Reject or intolerance of radiotherapy or chemotherapy due to the severe heart failure, emphysema, interstitial lung fibrosis, etc., or have a recurrence after surgery or a local progression after radiotherapy or chemotherapy; 4) No extrapulmonary metastases, or metastases were controlled and stable after treatment; 5) ECOG PS = 2; 6) Life expectancy > 6 months.
Exclusion criteria
Exclusion criteria: 1) With extensive, uncontrolled extrapulmonary metastases; 2) Past or present history of other malignant tumors (except cured basal cell carcinoma or squamous cell carcinoma of skin, or cervical carcinoma in situ); 3) WBC 2 mg/L, AST and/or ALT > 2 times of the upper limit); 5) Coagulation disorders (INR >1.5) or hemorrhagic diseases, or anticoagulant therapy; 6) Patients with active infection requiring antibiotic treatment; 7) Allergic to contrast agent; 8) During pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Response rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival;Overall survival;Quality of life; | — |
Countries
China
Contacts
Public ContactBie Zhixin
Beijing Hospital
Outcome results
None listed